Casma Therapeutics Inc.

Merck & Co., Inc. is making its latest foray into drugs targeting a lysosomal ion channel that plays a role in neurodegenerative diseases with its acquisition of Caraway Therapeutics , a venture cap

CG Oncology, Inc. led the latest group of private biotechnology companies that completed $100m-plus venture capital mega-rounds, with a $120m series E financing announced on 15 November, followed clo

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck & Co. Seeks NASH Momentum From Al

Neogene Therapeutics, Inc. , with a $110m series A venture capital round, led a group of five biopharmaceutical companies that revealed $320m in significant VC financings on a single day. The New York